Abstract

Prion diseases are a unique group of infectious chronic neurodegenerative disorders to which there are no cures. Although prion infections do not stimulate adaptive immune responses in infected individuals, the actions of certain immune cell populations can have a significant impact on disease pathogenesis. After infection, the targeting of peripherally-acquired prions to specific immune cells in the secondary lymphoid organs (SLO), such as the lymph nodes and spleen, is essential for the efficient transmission of disease to the brain. Once the prions reach the brain, interactions with other immune cell populations can provide either host protection or accelerate the neurodegeneration. In this review, we provide a detailed account of how factors such as inflammation, ageing and pathogen co-infection can affect prion disease pathogenesis and susceptibility. For example, we discuss how changes to the abundance, function and activation status of specific immune cell populations can affect the transmission of prion diseases by peripheral routes. We also describe how the effects of systemic inflammation on certain glial cell subsets in the brains of infected individuals can accelerate the neurodegeneration. A detailed understanding of the factors that affect prion disease transmission and pathogenesis is essential for the development of novel intervention strategies.

Highlights

  • Prion diseases, referred to as transmissible spongiform encephalopathies, are subacute, infectious, neurodegenerative diseases that affect humans and some domestic and free-ranging animal species to which there are no effective treatments

  • We focus on the peripherally-acquired prion diseases such as natural sheep scrapie, chronic wasting disease in cervid species and bovine spongiform encephalopathy (BSE) in cattle, as these are considered to be transmitted by the oral route through the ingestion of food or pasture contaminated with prions

  • We provide a detailed account of how inflammation, ageing and pathogen co-infection can have a significant impact on prion disease pathogenesis and susceptibility by causing changes to the abundance, function and activation status of specific immune cell populations

Read more

Summary

Introduction

Referred to as transmissible spongiform encephalopathies, are subacute, infectious, neurodegenerative diseases that affect humans and some domestic and free-ranging animal species to which there are no effective treatments. Other studies revealed that this peripheral phase of prion replication in SLO such as the spleen was important for the efficient transmission of disease to the CNS [21]. These studies were soon accompanied by others that showed how modulation of the immune system around the time of peripheral exposure could have a profound influence prion disease pathogenesis [22,23,24,25]. We provide a detailed account of how inflammation, ageing and pathogen co-infection can have a significant impact on prion disease pathogenesis and susceptibility by causing changes to the abundance, function and activation status of specific immune cell populations

Splenectomy before Intraperitoneal Prion Infection Extends Survival Times
Prions First Replicate upon Follicular Dendritic Cells in SLO
FDC Trap Prions in a Complement-Dependent Manner
Ageing Affects FDC and their Ability to Trap Prions
PrPC Abundance on FDC Affects Disease Susceptibility
The Distance between FDC and Nerves Is Rate Limiting
Propagation of Prions to FDC in Peyer’s Patches
M Cells are the Gate Keepers of Prions in the Intestine
Conventional DC Shuttle Prions to FDC
Macrophages Can Destroy Prions
Chronic Inflammation Can Facilitate Prion Targeting in Non-SLO Tissues
Gastrointestinal Helminths
Pathogenic Bacteria
CNS Prion Disease
The Yin and Yang of the Microglia
Microglia Can Phagocytose and Destroy Prions in the Steady State
Microglia Engulf Apoptotic Bodies
Microglia Can Cause Neurodegeneration
Microglia as Therapeutic Targets
The Commensal Gut Microbiome Constitutively Modulates Microglia Status
Reactive Astrocytes
Microglia Can Modify the Phenotype of Reactive Astrocytes
Systemic Inflammation and Reactive Astrocyte Activation During Prion Disease
Virus Co-Infections
Gastrointestinal Helminth Parasites
The Contrasting Effects of Type I Interferons
COVID-19
Findings
10. Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call